Acetylsalicylic acid Withdrawn Phase 1 Trials for Squamous Cell Carcinoma (SCC) / Head and Neck Carcinoma Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00937300T-cell Based Immunotherapy for Head and Neck Cancer